Stocktoria
Keros Therapeutics, Inc. KROS
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-04-08
Keros Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 2,513,244 | $114.9M | 6.64% |
| CITADEL ADVISORS LLC | 553,766 | $6.1M | 1.46% |
| D. E. Shaw & Co., Inc. | 509,608 | $5.6M | 1.35% |
| RENAISSANCE TECHNOLOGIES LLC | 453,482 | $5.0M | 1.2% |
| AQR CAPITAL MANAGEMENT LLC | 406,563 | $4.5M | 1.07% |
| TWO SIGMA INVESTMENTS, LP | 363,835 | $4.0M | 0.96% |
| Point72 Asset Management, L.P. | 109,015 | $1.2M | 0.29% |
| MILLENNIUM MANAGEMENT LLC | 106,858 | $1.2M | 0.28% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.